Követés
David Heidenreich
David Heidenreich
E-mail megerősítve itt: pharmchem.uni-frankfurt.de
Cím
Hivatkozott rá
Hivatkozott rá
Év
A chemical toolbox for the study of bromodomains and epigenetic signaling
Q Wu, D Heidenreich, S Zhou, S Ackloo, A Krämer, K Nakka, ...
Nature communications 10 (1), 1-14, 2019
1142019
Discovery of an MLLT1/3 YEATS domain chemical probe
M Moustakim, T Christott, OP Monteiro, J Bennett, C Giroud, J Ward, ...
Angewandte Chemie International Edition 57 (50), 16302-16307, 2018
652018
Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
E Watts, D Heidenreich, E Tucker, M Raab, K Strebhardt, L Chesler, ...
Journal of medicinal chemistry 62 (5), 2618-2637, 2019
562019
Discovery and optimization of a selective ligand for the switch/sucrose nonfermenting-related bromodomains of polybromo protein-1 by the use of virtual screening and hydration …
V Myrianthopoulos, N Gaboriaud-Kolar, C Tallant, ML Hall, S Grigoriou, ...
Journal of medicinal chemistry 59 (19), 8787-8803, 2016
542016
Selective targeting of bromodomains of the Bromodomain-PHD Fingers family impairs osteoclast differentiation
JC Meier, C Tallant, O Fedorov, H Witwicka, SY Hwang, RG van Stiphout, ...
ACS chemical biology 12 (10), 2619-2630, 2017
422017
Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)
D Heidenreich, M Moustakim, J Schmidt, D Merk, PE Brennan, O Fedorov, ...
Journal of medicinal chemistry 61 (23), 10929-10934, 2018
402018
Structural insights into interaction mechanisms of alternative piperazine-urea YEATS domain binders in MLLT1
X Ni, D Heidenreich, T Christott, J Bennett, M Moustakim, PE Brennan, ...
ACS Medicinal Chemistry Letters 10 (12), 1661-1666, 2019
262019
Pan-SMARCA/PB1 bromodomain inhibitors and their role in regulating adipogenesis
M Wanior, F Preuss, X Ni, A Krämer, S Mathea, T Göbel, ...
Journal of medicinal chemistry 63 (23), 14680-14699, 2020
232020
Protein 19F-labeling using transglutaminase for the NMR study of intermolecular interactions
Y Hattori, D Heidenreich, Y Ono, T Sugiki, K Yokoyama, E Suzuki, ...
Journal of biomolecular NMR 68 (4), 271-279, 2017
182017
Dietary Compound Resveratrol Is a Pan-BET Bromodomain Inhibitor
LA Dutra, D Heidenreich, GDB Silva, C Man Chin, S Knapp, JL Santos
Nutrients 9 (11), 1172, 2017
162017
Covalent Modification of Bromodomain Proteins by Peptides Containing a DNA Damage‐Induced, Histone Post‐Translational Modification
MP Jacinto, D Heidenreich, S Müller, MM Greenberg
ChemBioChem 23 (22), e202200373, 2022
2022
Entdeckung einer chemischen Sonde für MLLT1/3‐YEATS‐Domänen
M Moustakim, T Christott, OP Monteiro, J Bennett, C Giroud, J Ward, ...
Angewandte Chemie 130 (50), 16540-16545, 2018
2018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–12